VT

Vipul Trivedi

Active Director Director DIN 08605064
DIN 08605064 First appointment Sep 2019 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2019
Shareholding value •••• Premium profile

About Vipul Trivedi

Data last updated:

Vipul Trivedi is a Director at Sanvariya Pharmaceuticals Private Limited (since 2019). The company operates in Pharma. Sanvariya Pharmaceuticals Private Limited reported revenue of ₹3.13 Cr (FY 2025).

DIN 08605064
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2019
Oldest Company Age 10 yrs
Largest company Sanvariya Pharmaceuticals Private Limited · ₹3.13 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20192016₹3.13 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Sanvariya Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Vipul Trivedi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vipul Trivedi

Vipul Trivedi currently holds 1 directorship: Sanvariya Pharmaceuticals Private Limited (Director, since 30 Sep 2019, revenue ₹3.13 Cr (FY 2025)).

Vipul Trivedi was first appointed on 30 Sep 2019 as Director at Sanvariya Pharmaceuticals Private Limited.

The current boards of Vipul Trivedi's companies include Deepkala Trivedi (Sanvariya Pharmaceuticals Private Limited), Ravina Kumari (Sanvariya Pharmaceuticals Private Limited), Shrawan Kumar (Sanvariya Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available